HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Rose Sheet

Executive Summary

Physicians Formula: Retailer destocking - to the point where retailers were ordering half of the number of pieces they did during the prior year - contributed to sales plunge in firm's first quarter of fiscal 2009, according to May 11 announcement. One of firm's largest retail customers announced in April it will no longer continue to sell Physicians Formula; retailer accounted for 16% of firm's gross sales in 2008. "We are obviously very disappointed with the decision made by this retail partner despite our strong performance and a long-term and very successful relationship. We are already taking actions to mitigate the impact of this decision including, but not limited to, reducing workforce levels, implementing cost controls, reducing capital expenditures, as well as re-evaluating various non-strategic marketing and administrative costs," Chairwoman and CEO Ingrid Jackel says. Sales were $20.2 mil. for the first quarter, compared with $42.7 mil. in the prior year. Firm is slowing its promotional activity to reduce costs. On the brighter side Mineral Wear makeup is gaining share in the masstige channel, and Physicians Formula bronzer and new eye makeup products have become best-sellers at retail, firm says

Physicians Formula: Retailer destocking - to the point where retailers were ordering half of the number of pieces they did during the prior year - contributed to sales plunge in firm's first quarter of fiscal 2009, according to May 11 announcement. One of firm's largest retail customers announced in April it will no longer continue to sell Physicians Formula; retailer accounted for 16% of firm's gross sales in 2008. "We are obviously very disappointed with the decision made by this retail partner despite our strong performance and a long-term and very successful relationship. We are already taking actions to mitigate the impact of this decision including, but not limited to, reducing workforce levels, implementing cost controls, reducing capital expenditures, as well as re-evaluating various non-strategic marketing and administrative costs," Chairwoman and CEO Ingrid Jackel says. Sales were $20.2 mil. for the first quarter, compared with $42.7 mil. in the prior year. Firm is slowing its promotional activity to reduce costs. On the brighter side Mineral Wear makeup is gaining share in the masstige channel, and Physicians Formula bronzer and new eye makeup products have become best-sellers at retail, firm says.

Inter Parfums: Launch of Burberry The Beat in the prior-year quarter plus soft consumer spending and unfavorable foreign exchange drove sales down 27% to $90.4 mil. in the first quarter of fiscal 2009, according to Inter Parfums' May 11 release. Firm's European operations booked $82 mil. in revenue, dwarfing U.S. sales of $8.4 mil. Net income declined 35% to $7.3 mil. Firm down-adjusted advertising and promotional spending in the quarter while rolling out men's version of Burberry The Beat, Lanvin L'Homme Sport , and in the U.S. a new Gap scent called Close . This year Inter Parfums plans to launch new scents from Paul Smith , Quicksilver and Van Cleef & Arpels .

Unilever: New advertising for Dove bar soap and recently launched products such as Degree Clinical Protection deodorants paid off in firm's fiscal 2009 first quarter, with personal-care sales increasing 4% to roughly $3.8 bil., firm says May 7. Axe hair-care items and Vaseline for Men cited as strong performers in categories where consumers generally were "paring back," Unilever says. During the quarter firm also launched "hair minimizing" Dove deodorant in Europe and Latin America. Overall Q1 sales totaled $12.89 bil., slightly down from the prior year, including a negative currency effect of 2%, company notes. Underlying sales growth was 4.8%. Firm completed acquisition of TIGI professional hair care in April; acquisition fattens Unilever's portfolio of premium brands in the U.S. and Europe (1 (Also see "Unilever Catapulted Into Professional Hair Care With TIGI Acquisition" - HBW Insight, 2 Feb, 2009.), p. 9).

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016166

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel